Market Analysis and Insights: Global Blood Bank Analyzers Market
Due to the COVID-19 pandemic, the global Blood Bank Analyzers market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Blood Bank Analyzers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The United States Blood Bank Analyzers market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the United States is % in 2021, while Chinese percentage is %, and it is predicted that China's share will reach % in 2028, trailing a CAGR of % through the analysis period.
The global key manufacturers of Blood Bank Analyzers include Abbott, Beckman Coulter, BD, Biokit, BioMerieux, Bio-Rad, DiaSorin, Fujirebio and HOLOGIC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In United States, in terms of revenue, in 2021, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Blood Bank Analyzers Scope and Market Size
The global Blood Bank Analyzers market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Blood Bank Analyzers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Fully Automatic Analyzers
Semi-Automatic Analyzers
Segment by Application
Hospitals
Clinics
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Abbott
Beckman Coulter
BD
Biokit
BioMerieux
Bio-Rad
DiaSorin
Fujirebio
HOLOGIC
Roche
Siemens
Johnson & Johnson
Tecan
Novartis
Diagast
Grifols
Immucor
Innogenetics
Orchid CellMark
Proteome Sciences